TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/5/20 17:32 | 10/1/20 | LOGC | Logicbio Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Chimovits Erez | MA | DT | P | 8,889 | 6.00 | 0 | 1,481 | 296 | I | ||||||||||||||||
12/20/19 13:56 | 12/18/19 | PHGE | Biomx Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Chimovits Erez | L3 | DT | P.m | 36 | 8.90 | 0 | 4 | 0 | 2,313 | I | |||||||||||||||
12/12/19 18:54 | 12/10/19 | PHGE | Biomx Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Chimovits Erez | L3 | DT | P.m | 78 | 8.85 | 0 | 9 | 0 | 2,309 | I | |||||||||||||||
12/9/19 20:19 | 12/5/19 | PHGE | Biomx Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Chimovits Erez | L3 | DT | P.m | 86 | 8.40 | 0 | 10 | 0 | 2,301 | I | |||||||||||||||
5/6/19 17:28 | 5/2/19 | NVUS | Novus Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chimovits Erez | CA | D | P.d | 2,003 | 3.10 | 0 | 646 | 25 | 3,183 | I | |||||||||||||||
10/25/18 18:24 | 10/23/18 | LOGC | Logicbio Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Chimovits Erez | MA | D | P.d | 4,900 | 10.00 | 0 | 490 | 16 | 3,488 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |